In contrast, the majority of patients with SMA type 1 and type 2 have two and three copies of SMN2, respectively, experiencing rapid neuromuscular decline around the ages of 2 and 13 years.106, 107. Here, SMN2 is linked to spinal muscular atrophy, type 1.